Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03936114 · ClinicalTrials.gov registry record · NA

Stress Management and Resiliency Training (SMART) for Family Medicine Residents at Eglin AFB

A NA study of Stress and Quality of Life, sponsored by Laura Rhaney.

Completed
Registry status
NA
Development phase
28
Enrollment target
1
Study location

NCT03936114: Completed NA study of Stress and Quality of Life, sponsored by Laura Rhaney.

NCT03936114 is a NA study of Stress and Quality of Life that has completed, run by Laura Rhaney. The registered enrollment target is 28 participants, below the 786-participant average among 152 other Stress trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03936114, a NA study of Stress and Quality of Life, has completed, sponsored by Laura Rhaney.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target
1
Study location

Study Summary

This research seeks to identify if the practice of the SMART program mindfulness decreases stress and increase resilience in family medicine residents.

Primary Outcome

Dispositional mindfulness, i.e. open or receptive awareness of and attention to what is taking place in the present. To score the scale, compute a mean of the 15 questions. Higher scores reflect higher levels of dispositional mindfulness.

Conditions Studied

Interventions

  • BEHAVIORAL SMART

Study Locations (1)

Florida

  • 96th Medical Group - Eglin Air Force Base

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2019-05-15
Est. Completion 2020-10-27
Phase NA
Laura Rhaney

1 total trials

What the finished NCT03936114 record still lists

NCT03936114 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 786-participant average among 152 other Stress trials with a reported enrollment target (96% lower).

The record links to 2 conditions, with Stress appearing as the primary indexed condition, and to 1 intervention - of which SMART is the first listed.

NCT03936114 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT03936114 about?

NCT03936114 is a clinical study titled "Stress Management and Resiliency Training (SMART) for Family Medicine Residents at Eglin AFB". This research seeks to identify if the practice of the SMART program mindfulness decreases stress and increase resilience in family medicine residents.

What is the current status of trial NCT03936114?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2019-05-15. Estimated completion is 2020-10-27.

What conditions does trial NCT03936114 study?

This clinical trial studies the following conditions: Stress, Quality of Life.

What interventions are being tested in trial NCT03936114?

The interventions under investigation include: SMART (BEHAVIORAL).

Who is sponsoring clinical trial NCT03936114?

This trial is sponsored by Laura Rhaney, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03936114 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03936114's enrollment target sits among peer trials

28 138th of 152 higher than 14 of 152 other Stress trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03471117 · 28 participants · Phase 4

    Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

  • NCT03523975 · 28 participants · Phase 1

    Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

  • NCT03608631 · 28 participants · Phase 1

    iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

  • NCT03810651 · 28 participants · Early Phase 1

    Pencil Beam Scanning in Patients With Renal Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03936114, the US trial registry maintained by the National Library of Medicine. NCT03936114 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.